Gain- and loss-of-function experiments demonstrated that overexpression of LINC00675 attenuated the proliferation, migration, and invasion ability of BC cells, while knockdown of LINC00675 enhanced these cellular phenotypes. Here, TMEM238L is linked to breast cancer.